In contrast to our observation that the loss of C/EBPδ is associated with increased lymph node metastasis and subsequent poor prognosis, it has recently been shown that C/EBPδ amplification drives tumor metastasis in urothelial carcinoma [31]. This evidence concerns the gene CEBPD and urothelial carcinoma.